With per-person pharmacy costs increasing, employers and benefits advisors are looking to integrated clinical management to reduce the total cost of care while supporting whole-person health and protecting workforce productivity.

One employer market issue getting some analyst attention is stop-loss prices.

Mood and anxiety disorders account for the largest aggregate costs, while substance use disorders carry the highest spending per treated patient.

The 529 Retirement Enhancement Act of 2026 eliminates the $35,000 lifetime limit.